WeVote

Bill

Bill

HD 3919

An Act improving maternal and child health related to Hyperemesis Gravidarum

194th Legislature (2025-2026) Introduced by Vanna Howard

Bill establishes clinical standards and insurance coverage for Hyperemesis Gravidarum to improve diagnosis, treatment access, and maternal health outcomes during pregnancy.

0
WeVote Research Nonpartisan
Bill Summary · HD 3919

Legislative bill overview

HD 3919 seeks to improve maternal and child health outcomes by addressing Hyperemesis Gravidarum (severe pregnancy-related nausea and vomiting). The bill likely establishes clinical guidelines, insurance coverage requirements, or healthcare provider training related to this condition. It aims to ensure pregnant individuals with this serious condition receive timely diagnosis and appropriate treatment.

Why is this important

Hyperemesis Gravidarum affects approximately 0.3-2% of pregnancies and can lead to severe dehydration, electrolyte imbalances, weight loss, and mental health complications if untreated. Many pregnant individuals face delayed diagnosis, inadequate treatment access, or insufficient provider education about the condition, resulting in preventable hospitalizations and poor outcomes. Addressing this gap could reduce maternal morbidity and improve quality of life during pregnancy.

Potential points of contention

  • Healthcare cost implications: Mandated insurance coverage and treatment protocols may increase healthcare expenses, with debates over who bears these costs
  • Clinical definition disagreement: Medical professionals may dispute diagnostic criteria, severity thresholds, or which treatments should be considered standard of care
  • Provider burden: New training requirements or clinical guidelines could impose compliance costs on healthcare facilities and practitioners

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.